Viewing data from:

WERA

ANDA

ETHINYL ESTRADIOL; NORETHINDRONE | A091204 | NOVAST LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: TRI-NORINYL 28-DAY(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Wera (2023)

Total Spending

$16K

Total Claims

461

Beneficiaries

Avg Cost/Unit

$0.70

Spending Trend

$23K(2019)→$23K(2020)→$24K(2021)→$18K(2022)→$16K(2023)

YoY Change:+0.4%

5yr CAGR:-1.2%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.035MG;0.5MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Mar 27, 2012

No patent or exclusivity listings for this strength.